Method for detecting a plasmodium infection

Patent metadata

Field	Value
Publication number	US-9605293-B2
Application number	US-201113996948-A
Country	US
Kind code	B2
Filing date	Dec 20, 2011
Priority date	Dec 23, 2010
Publication date	Mar 28, 2017
Grant date	Mar 28, 2017

Abstract

The invention relates to a method for detecting a plasmodium infection in a patient blood sample, wherein a differential analysis of the polymorphonuclear neutrophil granulocytes in the sample is performed, and the distribution of the cell volume and the cell density, the number of thrombocytes in the sample, and the distribution of the cell density of the thrombocytes in the sample is determined.

First claim

The invention claimed is:

1. A method for detecting an indication of a possible plasmodium infection in a patient blood sample, the method comprising the steps of:
a) obtaining a blood sample from a patient suspected of having a possible plasmodium infection;
b) performing a differential analysis of polymorphonuclear neutrophil granulocytes in the sample and determining a distribution of cell volume and cell density by scattered light measurement using a hematology system;
c) coloring the neutrophil granulocytes and determining the volume distribution of the colored neutrophil granulocytes;
d) determining a number of thrombocytes in the sample by scattered light measurement using a hematology system;
e) determining a distribution of cell density of the thrombocytes in the sample by scattered light measurement using a hematology system;
f) obtaining sample parameters from the values determined in steps b)-d), wherein the sample parameters include the number of thrombocytes in the blood sample (PLT), the distribution of cell density of the thrombocytes in the blood sample (MPC), and the distribution of cell density of polymorphonuclear neutrophil granulocytes in the blood sample (PMNx);
g) evaluating the parameters in relation to a prespecified criterion, wherein, if the criterion is fulfilled, presuming a possible plasmodium infection is present, and wherein the criterion is expressed as (PLT×MPC)/100 <47 and PMNx +0.1635×(PLT×MPC)/100 <33; and
h) diagnosing a patient as being possibly infected with plasmodium if the patient blood sample indicates the presence of a possible plasmodium infection.

2. The method as claimed in claim 1 , wherein the plasmodium infection involves an infection with Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae or Plasmodium knowlesi.

3. The method as claimed in claim 1 , wherein an additional spherization and differential analysis of reticulocytes and erythrocytes is performed by scattered light measurement and absorption measurements.

4. The method as claimed in claim 1 , wherein, after the coloring of all neutrophil granulocytes in the sample, a differential analysis is undertaken by scattered light measurement and absorption.

5. The method as claimed in claim 4 wherein the coloring is performed with 3-chloro-1-naphthol as a substrate.

6. The method as claimed in claim 1 , wherein the standard deviation of the volume distribution and absorption distribution of all neutrophil granulocytes after the coloring are used as additional parameters.

7. The method according to claim 6 wherein an increase of the parameters is predictive for the presence of a possible plasmodium infection.

8. The method as claimed in claim 1 , wherein the determination of a distribution of cell volume and cell density in step b) includes using a suitable lysis reagent to lyse eosinophils and neutrophils but not basophil leukocytes and measuring the cell volume and cell density of the unlysed basophil leukocytes.

9. The method as claimed in claim 1 , wherein the determination of a distribution of cell volume and cell density in step b) includes performing a specific lysis of all cells except for basophil leukocytes, coloring the unlysed basophil leukocytes instead of step c), and measuring the cell volume and cell density of the unlysed basophil leukocytes from a scattered light diagram created using low and high angle scattering.

10. The method as claimed in claim 1 , which is performed by an automated cell counting device.

Assignees

• Hayden Oliver
• Van Den Boogaart Jan
• Siemens Healthcare Diagnostics Products Gmbh

Inventors

• Hayden Oliver
• Van Den Boogaart Jan

Classifications

• C12Q1/02 Primary

  involving viable microorganisms · CPC title

• C12Q1/04 Primary

  Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(C12Q1/6897 takes precedence)} · CPC title

• G01N2015/008

  Physics · mapped topic

• G01N2333/445

  Plasmodium · CPC title

• G01N15/1456

  without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals · CPC title